Format

Send to

Choose Destination
J Heart Lung Transplant. 2012 Feb;31(2):117-26. doi: 10.1016/j.healun.2011.12.001.

The Fourth INTERMACS Annual Report: 4,000 implants and counting.

Author information

1
Division of Cardiovascular, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. jkirklin@uab.edu

Abstract

The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more than 4,000 patients entered into the database, the evolution of pump technology, strategy at implant, and pre-implant patient profiles are chronicled. A risk factor analysis of the entire adult primary implant population is provided, and the recent composition of patient profiles is examined. Current actuarial survival with continuous-flow pumps exceeds 80% at 1 year and 70% at 2 years.

PMID:
22305376
DOI:
10.1016/j.healun.2011.12.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center